Medication info
AmoZaltan Tablet 10/50 mg

AmoZaltan Tablet 10/50 mg

Prescription medicationTabletOral
Ingredient · strength
Losartan Potassium›50mg / 1 tabletAmlodipine Camsylate›15.68mg / 1 tablet
Manufacturer / importer
Hanmi Pharmaceutical Co., Ltd.
Appearance
Pale pink, oblong film-coated tablet
Packaging
30 tablets/bottle, 300 tablets/bottle
Approval status
Active

MFDS item code 201006206 · Approved 2010.10.15 · Insurance code 643505670

Summary

Main use
Treatment of essential hypertension and initial therapy for Stage 2 hypertension
Who takes it
Adults · Children
Adult dose
The recommended dose of this medicine is 1 tablet once daily, taken with water, with or without food. If possible, it is recommended to take it at the same time each day (e.g., in the morning). Before administering this medicine, it is recommended to adjust the dose using the individual components (amlodipine or losartan). However, if blood pressure is not controlled with monotherapy with either component, switching directly to this medicine may be considered as follows: - 5/50 milligrams: For patients whose blood pressure is not adequately controlled with amlodipine 5 milligrams or losartan 50 milligrams as monotherapy. - 5/100 milligrams: For patients whose blood pressure is not adequately controlled with amlodipine 5 milligrams or losartan 100 milligrams as monotherapy. Patients taking amlodipine and losartan concomitantly may switch to this medicine (a combination product containing the same amounts of each active ingredient) for convenience. Before administering this medicine as initial therapy to patients with stage 2 hypertension, the decision to administer it should take into account baseline blood pressure, target blood pressure, and the expected likelihood of achieving the treatment target with combination therapy compared with monotherapy. The usual dose is 5/50 milligrams once daily. If blood pressure is not adequately controlled after 2 weeks of treatment, the dose may be increased to 10/50 milligrams once daily. ∘ Patients with renal impairment : No dosage adjustment is necessary in patients with mild renal impairment (e.g., creatinine clearance 20∼50mL/min); however, use of this medicine is not recommended in patients with moderate to severe renal impairment (e.g., creatinine clearance < 20 mL/min) or in patients on dialysis. ∘ Patients with reduced intravascular volume : Use of this medicine is not recommended in a small number of patients with reduced intravascular volume (e.g., patients receiving treatment with high doses of diuretics). (See Section 1, Warnings, in Precautions for Use.) ∘ Patients with hepatic impairment : Use of this medicine is not recommended in patients with a history of hepatic impairment who require a reduced dose of losartan (e.g., 25 milligrams once daily). ∘ Elderly patients : In patients aged 75 years or older, the recommended initial dose of losartan is 25 milligrams once daily; therefore, use of this medicine as initial treatment is not recommended.
Child dose
The safety and efficacy of this medicine have not been established in pediatric patients aged 18 years or younger; therefore, its use is not recommended.

Ingredients

Manufacturer
Hanmi Pharmaceutical Co., Ltd.

Efficacy & effects

Treatment of essential hypertension and initial therapy for Stage 2 hypertension

  • Essential hypertension
  • stage 2 hypertension
View approved original text

This medication is used for patients with essential hypertension whose blood pressure is not adequately controlled with amlodipine or losartan monotherapy. It is also suitable for initial treatment in stage 2 hypertension patients who require combination therapy to reach the target blood pressure. It helps in effectively controlling hypertension and reducing the risk of cardiovascular complications.

How to take

Adult dose

The recommended dose of this medicine is 1 tablet once daily, taken with water, with or without food. If possible, it is recommended to take it at the same time each day (e.g., in the morning). Before administering this medicine, it is recommended to adjust the dose using the individual components (amlodipine or losartan). However, if blood pressure is not controlled with monotherapy with either component, switching directly to this medicine may be considered as follows: - 5/50 milligrams: For patients whose blood pressure is not adequately controlled with amlodipine 5 milligrams or losartan 50 milligrams as monotherapy. - 5/100 milligrams: For patients whose blood pressure is not adequately controlled with amlodipine 5 milligrams or losartan 100 milligrams as monotherapy. Patients taking amlodipine and losartan concomitantly may switch to this medicine (a combination product containing the same amounts of each active ingredient) for convenience. Before administering this medicine as initial therapy to patients with stage 2 hypertension, the decision to administer it should take into account baseline blood pressure, target blood pressure, and the expected likelihood of achieving the treatment target with combination therapy compared with monotherapy. The usual dose is 5/50 milligrams once daily. If blood pressure is not adequately controlled after 2 weeks of treatment, the dose may be increased to 10/50 milligrams once daily. ∘ Patients with renal impairment : No dosage adjustment is necessary in patients with mild renal impairment (e.g., creatinine clearance 20∼50mL/min); however, use of this medicine is not recommended in patients with moderate to severe renal impairment (e.g., creatinine clearance < 20 mL/min) or in patients on dialysis. ∘ Patients with reduced intravascular volume : Use of this medicine is not recommended in a small number of patients with reduced intravascular volume (e.g., patients receiving treatment with high doses of diuretics). (See Section 1, Warnings, in Precautions for Use.) ∘ Patients with hepatic impairment : Use of this medicine is not recommended in patients with a history of hepatic impairment who require a reduced dose of losartan (e.g., 25 milligrams once daily). ∘ Elderly patients : In patients aged 75 years or older, the recommended initial dose of losartan is 25 milligrams once daily; therefore, use of this medicine as initial treatment is not recommended.

Child dose

The safety and efficacy of this medicine have not been established in pediatric patients aged 18 years or younger; therefore, its use is not recommended.

Precautions

This drug can cause serious harm to the fetus or newborn if taken during pregnancy, especially in the second and third trimesters, so it should be discontinued immediately upon confirmation of pregnancy. Taking this medication during pregnancy may reduce the fetal kidney function, leading to decreased amniotic fluid volume, which can result in limb contractures, craniofacial deformities, and lung development issues in the fetus. Patients with a reduced effective blood volume, such as those on diuretics, may experience hypotension symptoms when first taking this medication, thus caution is needed. It should not be used in patients with hypersensitivity to this drug, pregnant women, those with severe liver dysfunction, severe aortic stenosis, or in shock. This drug should be used with caution in patients with decreased effective blood volume, those on strict salt restrictions, moderate to severe renal impairment, or hyperkalemia. Possible side effects include dizziness, headache, drowsiness, weakness, chest discomfort, edema, dyspepsia, pruritus, palpitations, orthostatic hypotension, and respiratory difficulties. During treatment, avoid hazardous activities such as working at heights or operating vehicles due to dizziness from blood pressure lowering. Patients with severely impaired liver function or poor kidney function should consult a physician before taking this medication, and caution is advised when taking potassium supplements or potassium-sparing diuretics as potassium levels can increase. This drug may pose risks to the fetus during pregnancy and could be transmitted through breast milk during lactation, so its use is not recommended. Use in individuals under 18 years or over 75 years of age is not recommended. In cases of overdose, severe hypotension, tachycardia, and shock may occur, so immediate medical attention is required. This medication must be stored out of reach of children and should not be transferred to other containers.

Side effects

Hypotension, neonatal skull formation deficiency, anuria, renal failure, oligohydramnios, fetal limb spasticity, craniofacial deformity, pulmonary hypoplasia, prematurity, intrauterine growth restriction, patent ductus arteriosus, dizziness, headache, drowsiness, cerebral infarction, weakness, chest discomfort, chest pain, early satiety, peripheral edema, pit edema, abdominal discomfort, dyspepsia, nausea, gastroesophageal reflux disease, constipation, pruritus, urticaria, palpitations, flushing, orthostatic hypotension, facial flushing, dyspnea, cough, conjunctival injection, frequent urination, arthralgia, sleep apnea syndrome, uterine fibroids, uterine prolapse, hyperlipidemia, osteoporosis, diabetes, gastric ulcer, hypoglycemia, pneumonia, cerebral hemorrhage, death, sudden death, myocardial infarction, angina, sepsis, gastric cancer, position-related edema, tremor, nausea, shingles, hypercholesterolemia, unspecified lipid metabolism disorder, atherosclerosis, pulmonary edema, periodontal destruction, benign gastrointestinal neoplasm, cholelithiasis, cholangitis, liver cirrhosis, fracture, ligament injury, albuminuria, chronic renal failure, exacerbation of chronic renal failure, renal papillary necrosis, prostate hyperplasia, ovarian cyst, cataract, altered temperature sensation, fatigue, edema, dizziness, abdominal pain, nausea, weakness, lethargy, pain, weight gain, weight loss, hypotension, vasculitis, tension increase, sensory decrease, sensory abnormalities, peripheral neuropathy, syncope, taste abnormalities, tremor, erectile dysfunction, gynecomastia, changes in bowel habits, dry mouth, gastritis, gingival hypertrophy, pancreatitis, vomiting, hyperglycemia, arthralgia, low back pain, muscle cramps, myalgia, leukopenia, thrombocytopenia, insomnia, mood changes, hair loss, increased sweating, purpura, skin discoloration, toxic epidermal necrolysis, tinnitus, visual disturbances, increased urination frequency, urination disorders, nocturia, hepatitis, jaundice, elevated liver enzymes, skin erythema, papular rash, delayed recovery of vascular tone and blood pressure when using vasoconstrictors, vascular edema, vasculitis, anaphylactic reaction, abnormal liver function, intestinal vascular edema, lethargy, anemia, thrombocytopenia, rhabdomyolysis, taste abnormalities, dry cough, erythroderma, hyperkalemia, hyponatremia, elevated ALT, elevated serum creatinine, blood pressure reduction, loss of consciousness, acute hepatitis, fulminant hepatitis, anaphylactoid syndrome, excessive peripheral vasodilation, reflex tachycardia, systemic hypotension, shock, severe hypotension, bradycardia, vascular edema, vasculitis, vascular edema (causing airway obstruction), face/lips/pharynx/tongue swelling, laryngeal/glottic swelling due to vascular edema

Not everyone experiences these, and they can vary from person to person.

Storage

Store this medication in a tightly sealed container to prevent exposure to air and moisture, at room temperature between 1 to 30 degrees Celsius. Storing it this way will help maintain its effectiveness and ensure safe use.

Appearance and packaging

Appearance

Pale pink, oblong film-coated tablet

Package unit

30 tablets/bottle, 300 tablets/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.